You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 12, 2025

Drug Price Trends for CLOMIPRAMINE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for CLOMIPRAMINE

Average Pharmacy Cost for CLOMIPRAMINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CLOMIPRAMINE 25 MG CAPSULE 00406-8806-01 0.23515 EACH 2025-01-22
CLOMIPRAMINE 25 MG CAPSULE 00832-0630-11 0.23515 EACH 2025-01-22
CLOMIPRAMINE 75 MG CAPSULE 70756-0407-11 0.37458 EACH 2025-01-22
CLOMIPRAMINE 25 MG CAPSULE 16571-0683-03 0.23515 EACH 2025-01-22
CLOMIPRAMINE 25 MG CAPSULE 16571-0683-09 0.23515 EACH 2025-01-22
CLOMIPRAMINE 25 MG CAPSULE 00904-7038-07 0.23515 EACH 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for CLOMIPRAMINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
CLOMIPRAMINE HCL 50MG CAP Golden State Medical Supply, Inc. 60429-0289-01 100 83.36 0.83360 EACH 2023-06-15 - 2028-06-14 FSS
CLOMIPRAMINE HCL 75MG CAP Golden State Medical Supply, Inc. 51407-0759-01 100 86.37 0.86370 EACH 2023-11-15 - 2028-06-14 FSS
CLOMIPRAMINE HCL 75MG CAP Golden State Medical Supply, Inc. 51672-4013-06 30 186.47 6.21567 EACH 2023-06-15 - 2028-06-14 FSS
CLOMIPRAMINE HCL 75MG CAP AvKare, LLC 69315-0165-01 100 52.50 0.52500 EACH 2023-06-15 - 2028-06-14 FSS
CLOMIPRAMINE HCL 25MG CAP Golden State Medical Supply, Inc. 51672-4011-06 30 186.47 6.21567 EACH 2023-06-15 - 2028-06-14 FSS
CLOMIPRAMINE HCL 75MG CAP Golden State Medical Supply, Inc. 51672-4013-06 30 201.46 6.71533 EACH 2023-06-23 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Clomipramine

Market Overview

Clomipramine, a tricyclic antidepressant, is widely used to treat various mental health conditions, including obsessive-compulsive disorder (OCD), depression, panic attacks, and Tourette's syndrome. The market for clomipramine is expected to experience significant growth driven by several key factors.

Market Drivers

  • Increasing Prevalence of Mental Health Disorders: The rising prevalence of OCD and other mental health disorders globally is a major driver for the clomipramine market. According to market analyses, the increasing number of patients suffering from depression and anxiety disorders will continue to drive demand for clomipramine[1][4].
  • Growing Geriatric Population: The expanding geriatric population is another significant factor, as older adults are more likely to suffer from mental health issues that require treatment with antidepressants like clomipramine[1][4].
  • Advancements in Pharmaceutical Technology: Continuous advancements in pharmaceutical technology, including improved formulations that offer better patient compliance and fewer side effects, are expected to boost the market[4].
  • Increasing Healthcare Expenditure: Rising healthcare expenditure and growing awareness about mental health are also contributing to the market growth[1][4].

Market Segmentation

The clomipramine market is segmented based on several criteria:

  • Strength: Clomipramine is available in various strengths, including 10mg, 25mg, 50mg, and 75mg[1].
  • Application: It is used to treat a range of conditions, including OCD, depression, panic attacks, schizophrenia, and Tourette's syndrome[1][4].
  • Demographic: The market is segmented into adult, pediatric, and geriatric populations[1].
  • Dosage Form: Clomipramine is available in tablet and capsule forms, among others[1].
  • Route of Administration: The primary route of administration is oral[1][3].
  • End-Users: The market includes clinics, hospitals, and other healthcare facilities[1].
  • Distribution Channel: Distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies[1].

Geographical Analysis

  • North America: This region currently dominates the clomipramine market due to the presence of major key players, high disposable income, and well-developed healthcare infrastructure[1].
  • Asia-Pacific: This region is expected to grow significantly during the forecast period due to increasing research and development activities and growing government support[1].

Price Analysis

The prices of clomipramine can vary significantly based on the strength, quantity, and pharmacy.

  • Cost per Unit: For example, the cost for a 30-day supply of 50mg clomipramine oral capsules can range from $25.44 to $290.71, depending on the pharmacy and any discounts applied[2].
  • Price Trends: Historically, there have been significant price hikes in generic drugs, including clomipramine. For instance, the price of clomipramine increased dramatically from $35 to $605 in some cases, highlighting the volatility in pricing[5].

Challenges and Restraints

Despite the growth potential, the clomipramine market faces several challenges:

  • Side Effects: Clomipramine is associated with various side effects such as diarrhea, headache, nausea, vomiting, drowsiness, dry mouth, constipation, nervousness, and seizures, which can hamper market growth[1][4].
  • High Cost: The high cost of the drug, especially in regions with limited healthcare resources, is a significant barrier to market expansion[1][5].
  • Regulatory Challenges: Stringent regulatory frameworks and the lack of significant marketing initiatives can also limit the market presence of clomipramine[4].

Opportunities

The clomipramine market presents several opportunities for growth:

  • Research and Development: Ongoing clinical trials and research activities are expected to provide beneficial opportunities for the market. Advanced clinical research leading to novel drug approvals will fuel market expansion[1][3].
  • Pediatric Applications: There is potential for clomipramine in pediatric applications, particularly for treating anxiety disorders[4].
  • Non-Traditional Markets: Increasing acceptance of antidepressants in non-traditional markets offers additional growth opportunities[4].

Forecast and Growth Projections

The clomipramine market is expected to grow at a Compound Annual Growth Rate (CAGR) of 4.40% during the forecast period of 2022-2029. This growth is driven by the increasing prevalence of mental health disorders, advancements in pharmaceutical technology, and rising healthcare expenditure[1].

Key Takeaways

  • The clomipramine market is driven by the rising prevalence of OCD and other mental health disorders.
  • The market faces challenges from high drug costs and side effects.
  • Advancements in pharmaceutical technology and increasing healthcare expenditure are key growth drivers.
  • North America dominates the market, but Asia-Pacific is expected to grow significantly.
  • The market is segmented based on strength, application, demographic, dosage form, and distribution channel.

FAQs

Q: What is clomipramine used for? A: Clomipramine is used to treat various mental health conditions, including obsessive-compulsive disorder (OCD), depression, panic attacks, and Tourette's syndrome.

Q: What are the common side effects of clomipramine? A: Common side effects include diarrhea, headache, nausea, vomiting, drowsiness, dry mouth, constipation, nervousness, and seizures.

Q: How much does clomipramine cost? A: The cost of clomipramine can vary significantly, but a 30-day supply of 50mg oral capsules can range from $25.44 to $290.71, depending on the pharmacy and any discounts applied.

Q: What regions dominate the clomipramine market? A: North America currently dominates the market, but the Asia-Pacific region is expected to grow significantly during the forecast period.

Q: What are the growth projections for the clomipramine market? A: The market is expected to grow at a CAGR of 4.40% during the forecast period of 2022-2029.

Cited Sources

  1. Data Bridge Market Research: Global Clomipramine Market - Industry Trends and Forecast to 2029.
  2. Drugs.com: Clomipramine Prices, Coupons, Copay Cards & Patient Assistance.
  3. Data Bridge Market Research: Tricyclic Antidepressants Market Size & Growth Forecast By 2029.
  4. 360iResearch: Clomipramine Market Size & Share 2025-2030.
  5. GovInfo: WHY ARE SOME GENERIC DRUGS SKYROCKETING IN PRICE?

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.